APOBEC3B has cytidine deaminase activity against ssDNA, causing a series of GC to AT mutations [18], and can modify the genome in somatic cells in vitro and in high APOBEC3B-expressing cancer cells [11, 19]. The gene discussed is APOBEC3B; the disease is cancer.